Quixin (Levofloxacin Ophthalmic) - Indications and Dosage

INDICATIONS AND USAGE

QUIXIN^® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

AEROBIC GRAM-POSITIVE MICROORGANISMS

Corynebacterium species^*
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus pneumoniae
Streptococcus (Groups C/F)
Streptococcus (Group G)
Viridans group streptococci

AEROBIC GRAM-NEGATIVE MICROORGANISMS

Acinetobacter Iwoffii ^*
Haemophilus influenzae
Serratia marcescens ^*

^*Efficacy for this organism was studied in fewer than 10 infections.

DOSAGE AND ADMINISTRATION

Days 1 and 2:
Instill one to two drops in the affected eye(s) every 2 hours while awake, up to 8 times per day.
Days 3 through 7:
Instill one to two drops in the affected eye(s) every 4 hours while awake, up to 4 times per day.

HOW SUPPLIED

QUIXIN^® (levofloxacin ophthalmic solution) 0.5% is supplied in a white, low density polyethylene bottle with a controlled dropper tip and a tan, high density polyethylene cap in the following size:

5 mL fill in 5 cc container - NDC 68669-135-05

Storage

Store at 15° - 25°C (59° - 77°F).

Manufactured by:

Santen Oy, P. O. Box 33, FIN-33721 Tampere, Finland

Licensed from:

Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan

Marketed by:

VISTAKON^® Pharmaceuticals, LLC
Jacksonville, FL 32256 USA

U.S. PAT. NO. 5,053,407

March 2004 Version